COVID-19 Vaccination and Acute Anterior Uveitis—A Case Control Study
In this case control study and comparison with preceding years, we found no evidence to suggest an association between vaccination with the BNT162b2 (Pfizer-BioNTech<sup>®</sup>) COVID-19 vaccine and new-onset acute anterior uveitis.
Authors
- Assaf Rozenberg (ORCID: https://orcid.org/0000-0003-0339-5063)
- Amit Toledano (ORCID: https://orcid.org/0000-0002-3395-0868)
- Adi Einan‐Lifshitz (ORCID: https://orcid.org/0000-0002-0556-4898)
- Asaf Shemer (ORCID: https://orcid.org/0000-0002-4366-5438)
- Idan Hecht (ORCID: https://orcid.org/0000-0001-5634-0432)
- Biana Dubinsky‐Pertzov (ORCID: https://orcid.org/0000-0002-4998-8772)
- Eran Pras
- Aya Altarescu (ORCID: https://orcid.org/0000-0002-2678-1955)
Institutions
- Tel Aviv University (IL)
- Assaf Harofeh Medical Center (IL)
Publication Details
- Journal
- Vaccines
- Published
- 2025-02-12
- DOI
- https://doi.org/10.3390/vaccines13020176
- Citations
- 1
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.71